MedTrace Logo

A Registry Study of Biomarkers in Heart Failure

NCT03784833 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2019-04-23

No results posted yet for this study

Summary

The registry study aims to discover the prognostic value of bio-markers in heart failure

Conditions

Sponsors & Collaborators

  • Tianjin Medical University Second Hospital

    collaborator OTHER

  • Second Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER

  • Beijing Luhe Hospital

    collaborator OTHER

  • China-Japan Friendship Hospital

    collaborator OTHER

  • Beijing Institute of Heart, Lung and Blood Vessel Diseases

    lead OTHER

Principal Investigators

  • Jie Du, Dr · The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart,Lung and Blood Vessel Diseases

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2022-06-30
Completion
2024-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03784833 on ClinicalTrials.gov